Monoclonal Gammopathy of Undetermined Significance (MGUS)
Monitoring and management of MGUS.
Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Clinical Guidelines
British Society for Haematology Guidelines on the investigation and management of monoclonal gammopathy of undetermined significance
National
2021 European Myeloma Network review and consensus statement on MGUSLocal
Investigation and management of monoclonal gammopathy of undetermined significance (MGUS) (British Society for Haematology Guideline, 2023)Local
Monoclonal Gammopathy of Undetermined Significance (MGUS) Pocket Guide (ASH, 2016)Local
Monoclonal gammopathy of undetermined significance: a consensus statement (International Myeloma Working Group, 2010)Local